Deka Bank Deutsche Girozentrale Neurocrine Biosciences Inc Transaction History

Deka Bank Deutsche Girozentrale

  • $59.4 Billion
  • Q3 2025

A detailed history of Deka Bank Deutsche Girozentrale transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 115,973 shares of NBIX stock, worth $16.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
115,973
Previous 115,973 -0.0%
Holding current value
$16.8 Million
Previous $14.5 Million 11.65%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 30, 2025
SELL
$87.54 - $128.18 $21,885 - $32,045
-250 Reduced 0.22%
115,973 $14.5 Million
Q1 2025

Apr 30, 2025
BUY
$107.22 - $153.29 $26,805 - $38,322
250 Added 0.22%
116,223 $12.9 Million
Q3 2024

Oct 24, 2024
BUY
$114.58 - $153.15 $273,502 - $365,569
2,387 Added 2.1%
115,973 $13.2 Million
Q2 2024

Aug 08, 2024
SELL
$130.86 - $143.19 $345,077 - $377,592
-2,637 Reduced 2.27%
113,586 $15.2 Million
Q1 2024

Apr 24, 2024
BUY
$130.4 - $143.74 $6.08 Million - $6.7 Million
46,627 Added 67.0%
116,223 $15.9 Million
Q4 2023

Jan 24, 2024
BUY
$106.07 - $132.76 $1.63 Million - $2.04 Million
15,367 Added 28.34%
69,596 $9.14 Million
Q3 2023

Nov 13, 2023
BUY
$94.02 - $117.1 $183,809 - $228,930
1,955 Added 3.74%
54,229 $6.21 Million
Q2 2023

Jul 25, 2023
BUY
$89.53 - $104.87 $253,459 - $296,886
2,831 Added 5.73%
52,274 $4.92 Million
Q1 2023

Apr 24, 2023
SELL
$94.11 - $123.02 $12,422 - $16,238
-132 Reduced 0.27%
49,443 $4.88 Million
Q4 2022

Feb 01, 2023
BUY
$106.72 - $127.06 $53,466 - $63,657
501 Added 1.02%
49,575 $5.92 Million
Q3 2022

Nov 02, 2022
BUY
$92.03 - $107.81 $472,482 - $553,496
5,134 Added 11.68%
49,074 $4.99 Million
Q2 2022

Aug 03, 2022
SELL
$75.79 - $100.07 $6,593 - $8,706
-87 Reduced 0.2%
43,940 $4.28 Million
Q1 2022

Apr 28, 2022
BUY
$72.45 - $94.81 $92,156 - $120,598
1,272 Added 2.98%
44,027 $4.2 Million
Q4 2021

Feb 02, 2022
BUY
$79.65 - $106.22 $610,915 - $814,707
7,670 Added 21.86%
42,755 $3.58 Million
Q3 2021

Oct 22, 2021
SELL
$86.18 - $99.03 $61,877 - $71,103
-718 Reduced 2.01%
35,085 $3.31 Million
Q2 2021

Aug 05, 2021
BUY
$89.43 - $102.27 $61,170 - $69,952
684 Added 1.95%
35,803 $3.45 Million
Q1 2021

Apr 28, 2021
BUY
$87.57 - $119.4 $505,103 - $688,699
5,768 Added 19.65%
35,119 $3.33 Million
Q4 2020

Mar 12, 2021
SELL
$86.91 - $108.33 $126,627 - $157,836
-1,457 Reduced 4.73%
29,351 $2.74 Million
Q3 2020

Oct 29, 2020
BUY
$96.16 - $135.15 $2.34 Million - $3.29 Million
24,370 Added 378.53%
30,808 $2.97 Million
Q2 2020

Aug 04, 2020
BUY
$85.09 - $130.36 $174,434 - $267,238
2,050 Added 46.72%
6,438 $803,000
Q1 2020

May 14, 2020
SELL
$75.11 - $113.76 $175,006 - $265,060
-2,330 Reduced 34.68%
4,388 $399,000
Q4 2019

Feb 04, 2020
SELL
$86.8 - $118.57 $1.88 Million - $2.56 Million
-21,613 Reduced 76.29%
6,718 $739,000
Q3 2019

Nov 14, 2019
SELL
$83.82 - $101.5 $6.61 Million - $8.01 Million
-78,880 Reduced 73.57%
28,331 $2.56 Million
Q2 2019

Aug 01, 2019
BUY
$72.24 - $91.27 $2.54 Million - $3.21 Million
35,131 Added 48.74%
107,211 $8.83 Million
Q1 2019

May 10, 2019
BUY
$69.31 - $91.53 $661,910 - $874,111
9,550 Added 15.27%
72,080 $8.8 Million
Q4 2018

Feb 12, 2019
SELL
$68.32 - $124.36 $652,455 - $1.19 Million
-9,550 Reduced 13.25%
62,530 $4.42 Million
Q3 2018

Nov 09, 2018
SELL
$98.88 - $125.85 $150,297 - $191,292
-1,520 Reduced 2.07%
72,080 $0
Q2 2018

Aug 14, 2018
BUY
$75.3 - $105.99 $2.26 Million - $3.18 Million
30,000 Added 68.81%
73,600 $7.16 Million
Q1 2018

May 03, 2018
SELL
$75.88 - $92.43 $5.23 Million - $6.37 Million
-68,900 Reduced 61.24%
43,600 $3.61 Million
Q3 2017

Nov 06, 2017
BUY
$47.97 - $61.28 $5.4 Million - $6.89 Million
112,500
112,500 $6.02 Million

Others Institutions Holding NBIX

# of Institutions
725
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email